Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable amidase AmiD (acylamidase) (acylase) | 0.0038 | 0.076 | 0.5 |
Mycobacterium ulcerans | amidase | 0.0038 | 0.076 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1448 | 0.1381 |
Brugia malayi | Amidase family protein | 0.0038 | 0.076 | 0.0687 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.002 | 0.002 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.9081 | 0.9081 |
Mycobacterium ulcerans | amidase | 0.0038 | 0.076 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0132 | 0.0132 |
Brugia malayi | Amidase family protein | 0.0038 | 0.076 | 0.0687 |
Echinococcus multilocularis | glutamyl tRNA(Gln) amidotransferase subunit A | 0.0038 | 0.076 | 0.0741 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0586 | 0.0586 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1448 | 0.1334 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0132 | 0.0054 |
Mycobacterium ulcerans | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0038 | 0.076 | 0.5 |
Mycobacterium tuberculosis | Probable amidase AmiB2 (aminohydrolase) | 0.0038 | 0.076 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0586 | 0.0512 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0586 | 0.0567 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0586 | 0.0567 |
Brugia malayi | putative amidase | 0.0038 | 0.076 | 0.0687 |
Mycobacterium ulcerans | amidase | 0.0038 | 0.076 | 0.5 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.5549 | 0.5541 |
Mycobacterium ulcerans | amidase | 0.0038 | 0.076 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0038 | 0.076 | 0.5 |
Brugia malayi | hypothetical protein | 0.0286 | 0.9081 | 0.9074 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.5549 | 0.5541 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0586 | 0.0567 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0038 | 0.076 | 0.5 |
Plasmodium vivax | glutamyl-tRNA(Gln) amidotransferase subunit A, putative | 0.0038 | 0.076 | 0.5 |
Schistosoma mansoni | lamin | 0.0033 | 0.0586 | 0.046 |
Plasmodium falciparum | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0038 | 0.076 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0586 | 0.0586 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0078 | 0.0078 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0132 | 0.0112 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.5549 | 0.5541 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.9081 | 0.9079 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0586 | 0.0567 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0132 | 0.0132 |
Schistosoma mansoni | lamin | 0.0033 | 0.0586 | 0.046 |
Mycobacterium tuberculosis | Possible amidase (aminohydrolase) | 0.0038 | 0.076 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0586 | 0.046 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0586 | 0.0586 |
Mycobacterium ulcerans | amidase | 0.0038 | 0.076 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1514 | 0.1514 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.4333 | 0.4289 |
Mycobacterium tuberculosis | Probable amidase AmiC (aminohydrolase) | 0.0038 | 0.076 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0132 | 0.0112 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0874 | 0.0802 |
Loa Loa (eye worm) | amidase | 0.0038 | 0.076 | 0.076 |
Schistosoma mansoni | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0038 | 0.076 | 0.0636 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0132 | 0.0112 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0132 | 0.0112 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0586 | 0.0567 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0038 | 0.076 | 0.0636 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0586 | 0.0512 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0874 | 0.0752 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0132 | 0.0112 |
Echinococcus granulosus | glutamyl tRNAGln amidotransferase subunit A | 0.0038 | 0.076 | 0.0741 |
Mycobacterium leprae | PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE (SUBUNIT A) GATA (Glu-ADT SUBUNIT A) | 0.0038 | 0.076 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.4333 | 0.4333 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0038 | 0.076 | 0.0741 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.5549 | 0.5549 |
Onchocerca volvulus | 0.0058 | 0.1448 | 1 | |
Mycobacterium ulcerans | peptide amidase, GatA | 0.0038 | 0.076 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0132 | 0.0112 |
Mycobacterium tuberculosis | Probable amidase AmiA2 (aminohydrolase) | 0.0038 | 0.076 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1514 | 0.1447 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1514 | 0.1514 |
Echinococcus granulosus | lamin | 0.0033 | 0.0586 | 0.0567 |
Trypanosoma cruzi | amidase, putative | 0.0038 | 0.076 | 0.5 |
Trypanosoma brucei | fatty-acid amide hydrolase, putative | 0.0038 | 0.076 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0038 | 0.076 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.5549 | 0.5549 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0566 | 0.0566 |
Trypanosoma cruzi | amidase, putative | 0.0038 | 0.076 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.9081 | 0.9079 |
Mycobacterium leprae | PROBABLE AMIDASE AMIC (AMINOHYDROLASE) | 0.0038 | 0.076 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1514 | 0.1447 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.4333 | 0.4333 |
Loa Loa (eye worm) | amidase | 0.0038 | 0.076 | 0.076 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.5549 | 0.5514 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0132 | 0.0054 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1448 | 0.1334 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0038 | 0.076 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0038 | 0.076 | 0.0741 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0874 | 0.0874 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (binding) | 0.7943 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.8184 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.